Growing Demand Drives Contrast Media Injectors Market towards US$ 3 Billion by 2033, Reports FMI

According to a recent market study by Future Market Insights (FMI), the global market for contrast media injectors was valued at US$ 1.5 billion in 2022 and is anticipated to reach US$ 3 billion by 2033.

FMI, an ESOMAR-certified market research firm, estimates global contrast media injectors market revenues to reach US$ 1.5 Bn in 2022. In its new study, FMI takes a long-term optimistic view of the market, estimating global revenues to grow at 6.2% CAGR through 2030. The report opines that AI’s growing penetration in the healthcare sector will also rub off on the contrast media injectors industry during the next decade.

Key Takeaways of Contrast Media Injectors Market Study

• North America is expected to be the most lucrative region and account for more than 32% of revenue in the global contrast media injectors in 2022 and this trend is expected to continue during the forecast period
• Larger patient pool and increasing government support towards developing healthcare system in Asian countries are expected to propel the growth of the contrast media injectors market in the region
• AI is expected to speed up the process of injecting contrast media in the forecast period
• Increasing applications in orthopedic surgeries and neurosurgeries to bolster the market in the forecast period

“Development of advanced contrast media injectors including automated and IT/software technology at low cost is the major focus area of the manufacturers, which provides a competitive advantage” says an FMI Analyst.

New Product Launches and Approval – The Ongoing Trend

The market players are into getting their new products launched as well as approved to stay in the competition and also keep pace with the market scenario (that of continuing to innovate). The constructive steps in this regard are:

• In Apr 2022, Guerbet announced getting approved by the US FDA for manufacturing gadoterate meglumine (Dotarem) injection inside the US. Till late 2019, this production used to happen outside of the US.
• In Nov 2021, the US FDA approved an MRI contrast agent “Clariscan” for intravenous use in spine, brain (intracranial), and associated tissues.
• In Aug 2021, Bracco Diagnostics, Inc. announced getting approved by the US FDA for oral suspension of barium sulfate (Varibar Thin Liquid). The basic use of this contrast agent is detection and assessment of dysphagia.

Ask Analyst for Report Customization and Explore TOC & List of Figures @  https://www.futuremarketinsights.com/ask-question/rep-gb-823

What else is in the report?

Future market insights offer actionable insights and unique perspective on contrast media injectors market in its latest study, presenting historical demand assessment from 2014 – 2021 and projections from 2022–2030 based on product type (angiographic injectors, magnetic resonance imaging (MRI) injectors, computed tomography (CT) injectors), by end-user (hospital, ambulatory surgical centres, diagnostics centres) in seven key regions

Contrast Media Injectors Market by Category

By Product:

• CT Injectors
• MRI Injectors
• Cardio Injectors

Click here today to buy your full report @ https://www.futuremarketinsights.com/checkout/823

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Diagnostics Centers

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain:

Antimicrobial Wound Care Dressings Market Size: From 2023 to 2033, the global antimicrobial wound care dressings market is estimated to be worth US$ 1.38 billion, with a CAGR of 6.4%. The global antimicrobial wound dressings market is expected to reach US$ 2.57 billion by 2033.

Animal Wound Care Market Share: A newly released Animal Wound Care Market analysis report by Future Market Insights shows that global sales of in 2021 were held at US$ 1 billion. With 8.7%, the projected market growth from 2022 to 2032 is expected to be significantly higher than the historical growth.

Wound Skin Care Market Growth: The wound skin care market is estimated to secure a valuation of US$ 8.5 Billion in 2023 and is estimated to rise to US$ 13.2 Billion by 2033. The market is anticipated at a CAGR of 4.5% during the forecast period.

About FMI:

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs